Association of the Intestinal Microbiome with the Development of Neovascular Age-Related Macular DegenerationOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study asked whether gut microbiome composition and function are associated with neovascular age-related macular degeneration, a leading cause of blindness in the elderly. Researchers sequenced the gut metagenomes of patients and matched controls. Shotgun sequencing profiled microbial species using MetaPhlAn, and metabolic pathways were inferred with the HUMAnN pipeline. Because diet is a known risk factor for the disease, the team explored whether the microbiome could link nutrition to disease development.
Who was studied?
The study recruited 23 participants at the University Hospital Bern in Switzerland. Twelve had recent-onset neovascular age-related macular degeneration and were aged 50 or older. Eleven age- and sex-matched controls had no signs of the disease. People with bowel problems, chronic gastrointestinal disease, or recent antibiotic use were excluded. Stool samples were sequenced, generating on average about 20 million high-quality non-human reads per sample for analysis.
What were the most important findings?
The genera Anaerotruncus and Oscillibacter, plus Ruminococcus torques and Eubacterium ventriosum, were relatively enriched in patients with macular degeneration. Bacteroides eggerthii was enriched in controls. The microbiome shifted toward Firmicutes at the expense of Bacteroidetes, with Firmicutes at 29.0 percent in patients versus 20.4 percent in controls. Principal component analysis separated patients from controls by both species and pathway composition. Patient microbiomes were enriched in genes for L-alanine fermentation, glutamate degradation, and arginine biosynthesis, and depleted in fatty acid elongation genes.
What are the greatest implications of this study?
The results suggest gut microbiome differences may contribute to neovascular macular degeneration and could link diet to this common blinding disease. If specific taxa or pathways prove causal, dietary changes, probiotics, or antibiotics might one day help modify disease risk. The authors stress this cannot establish causation. The small sample may not represent the whole patient population, and genetic and dietary confounders remain possible.